Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 70,000 shares at $41.95 ($2.9M) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Open-market sale of $2.9M FATE by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.26 | 21,757 | $876K | 30.7% |
| 2 | $40.26 | 21,757 | $876K | 30.7% |
| 3 | $41.09 | 6,260 | $257K | 9.0% |
| 4 | $41.09 | 6,260 | $257K | 9.0% |
| 5 | $41.95 | 6,983 | $293K | 10.3% |
| 6 | $41.95 | 6,983 |
| $293K |
| 10.3% |
| Total | $40.75 avg | 70,000 | $2.9M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |